CIK 0001579428 · Large accelerated filer
Axsome Therapeutics, Inc.
Sign in to watch- Ticker
- AXSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 454241907
- Phone
- (212) 332-3241
- Business address
- ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK, NY, 10007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,086,500
- in 1 filing, $2.1M under 10b5-1 plans
Net −$2,086,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-17 | Pizzie Nick Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +48,237 | 48,237 | ||
| 2020-03-17 | Pizzie Nick Chief Financial Officer | Grant or award · Restricted Stock Units | +14,767 | 14,767 | ||
| 2020-03-17 | TABUTEAU HERRIOT CHIEF EXECUTIVE OFFICER | Grant or award · Employee Stock Option (Right to Buy) | +168,776 | 168,776 | ||
| 2020-03-17 | TABUTEAU HERRIOT CHIEF EXECUTIVE OFFICER | Grant or award · Restricted Stock Units | +51,691 | 51,691 | ||
| 2020-03-17 | Pizzie Nick Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +60,880 | 60,880 | ||
| 2020-03-17 | Pizzie Nick Chief Financial Officer | Grant or award · Restricted Stock Units | +18,645 | 18,645 | ||
| 2020-03-17 | Jacobson Mark L. Chief Operating Officer | Grant or award · Employee Stock Option (Right to Buy) | +60,880 | 60,880 | ||
| 2020-03-17 | Jacobson Mark L. Chief Operating Officer | Grant or award · Restricted Stock Units | +18,645 | 18,645 | ||
| 2020-03-17 | Marek David C Chief Commercial Officer | Grant or award · Employee Stock Option (Right to Buy) | +53,984 | 53,984 | ||
| 2020-03-17 | Marek David C Chief Commercial Officer | Grant or award · Restricted Stock Units | +16,533 | 16,533 | ||
| 2020-03-17 | JEFFS ROGER Director | Grant or award · Stock Option (Right to Buy) | +4,496 | 4,496 | ||
| 2020-03-17 | Coleman Mark Director | Grant or award · Stock Option (Right to Buy) | +3,308 | 3,308 | ||
| 2020-03-17 | Saad Mark E Director | Grant or award · Stock Option (Right to Buy) | +3,789 | 3,789 | ||
| 2020-01-10 | JEFFS ROGER Director | Option exercise | +9,127 | $9.00 | $82K | 65,747 |
| 2020-01-10 | JEFFS ROGER Director | Option exercise | +5,193 | $8.02 | $42K | 70,940 |
| 2020-01-10 | JEFFS ROGER Director | Option exercise | +11,000 | $4.95 | $54K | 81,940 |
| 2020-01-10 | JEFFS ROGER Director | Option exercise | +34,866 | $12.95 | $452K | 116,806 |
| 2020-01-10 | JEFFS ROGER Director | Option exercise · Stock Option (Right to Buy) | −9,127 | 0 | ||
| 2020-01-10 | JEFFS ROGER Director | Option exercise · Stock Option (Right to Buy) | −5,193 | 0 | ||
| 2020-01-10 | JEFFS ROGER Director | Option exercise · Stock Option (Right to Buy) | −11,000 | 0 |
Page 17 of 22 · 422 trades